SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

FPH Fisher & Paykel Healthcare Corporation Limited

Healthcare · Medical Instruments & Supplies · website · 7,357 employees
$36.79
52wk 26.51 – 37.78
Overall
71.1
Value
0.8
Growth
88.4
Health
97.6
Quality
100.0
Momentum
88.7
Dividend
54.2
Price
About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Price analytics

Returns

1 day -1.5%
1 week 1.3%
1 month 1.5%
3 months 9.9%
6 months 15.2%
1 year 10.7%
3 years 80.3%

Risk

Volatility (1y ann.) 24.6%
Beta vs ASX 200 0.81
Sharpe (1y) 0.38
VaR 95% (1-day) -2.3%
Max drawdown (1y) -23.1%
Off 1-year high -1.7%

Technicals

RSI(14) 69
vs 50DMA 3.1%
vs 200DMA 12.5%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 0.8
Trailing P/E
0
Forward P/E
0
PEG ratio
0
EV / EBITDA
0
Price / Book
0
Price / Sales
7
Growth 88.4
Revenue growth (1y)
100
Revenue CAGR (3y)
73
EPS growth (1y)
88
EPS CAGR (3y)
93
Financial Health 97.6
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
89
Debt / Equity
100
Quality (Profitability & Cash Flow) 100.0
Return on equity
100
Return on assets
100
Operating margin
100
Net margin
100
Cash conversion (OCF / net income)
—
Dividend / Income 54.2
Dividend yield (%)
20
Payout ratio
82
FCF dividend cover
62
Momentum 88.7
6-month return vs ASX 200
100
Price vs 200-day average
92
Price vs 50-day average
65
Position in 52-week range
91

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$21.64B
P/E (trailing)
57.48
P/E (forward)
41.68
EPS (trailing)
0.64
Dividend yield
1.2%
Payout ratio
54.0%
Beta
0.90
EV / EBITDA
28.02
Price / Book
12.69
ROE
23.4%
Operating margin
28.7%
Net margin
20.3%
Total cash
$461.10M
Total debt
$146.10M
Current ratio
2.31
Debt / Equity
0.07
Free cash flow
$399.41M
Avg volume
367,182
Latest annual results (FY ending 31 Mar 2026)
  • Revenue$2.31B
  • Gross profit$1.47B
  • Operating income$477.80M
  • Net income$468.50M
  • Diluted EPS0.79
  • Free cash flow$468.00M
  • Net debt-$315.00M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4
ANN $6.27B 21.3 71.5